Can viral envelope glycolipids produce auto-immunity, with reference to the CNS and multiple sclerosis?
- PMID: 6330601
- PMCID: PMC7168014
- DOI: 10.1111/j.1365-2990.1984.tb00335.x
Can viral envelope glycolipids produce auto-immunity, with reference to the CNS and multiple sclerosis?
Abstract
Many viruses, with lipid envelopes derived from the host cell membranes, have been implicated in the aetiology of multiple sclerosis (MS), and epidemiological studies support an infectious agent. Alternatively the disease is thought by other workers to be auto-immune in nature, and recently much attention has been focused on immunological sensitivity to glycolipids in MS patients. In this paper it is proposed that CNS demyelination could arise in susceptible individuals (HLA type) from an immune response to glycolipids, triggered by the carrier effect of one or more enveloped neurotropic viruses.
References
-
- Adams J.M., Brooks M.B., Fisher E.D. & Tyler C.S. (1970) Measles antibodies in patients with multiple sclerosis and with other neurological and non‐neurological diseases. Neurology 20, 1039–42. - PubMed
-
- Allison A.C. (1971) Unresponsiveness to self antigens. Lancet ii, 1401. - PubMed
-
- Arnon R., Crisp E., Kelly R., Ellison S.W., Myes L.W. & Tourtellotte W.W. (1980) Anti‐ganglioside antibodies in multiple sclerosis. Journal of the Neurological Science 26, 179–186. - PubMed
-
- Blough H.A. & Merlie J.P. (1970) The lipids of incomplete influenza virus. Virology 40, 68–92. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
